Mankai Ju

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0002-3570-8389

发表论文 18 篇 · 总被引 163 次 · h-index 3

代表论文

• Nonvascular role for vascular endothelial growth factor (VEGF): VEGFR‐1 and VEGFR‐2 activity is critical for neural retinal development (2001 · The FASEB Journal · 被引 144)
• Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials (2025 · Nature Medicine · 被引 9)
• Transforming growth factor–ß1 induction of vascular endothelial growth factor receptor–1: Mechanism of pericyte–induced vascular survival in vivo (2004 · Investigative Ophthalmology & Visual Science · 被引 3)
• The effectiveness and safety of various treatments for hemophilia in China: a literature review and evidence mapping (2025 · Hematology · 被引 2)
• Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F -Mutated Essential Thrombocythemia (2024 · Clinical Cancer Research · 被引 2)
• Daratumumab in patients with immune thrombocytopenia: a single-center, open-label, phase 2 trial (2026 · EClinicalMedicine · 被引 1)